Vascular inflammation
Drug research and approvals for vascular inflammation: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 165 studies of vascular inflammation are recruiting on ClinicalTrials.gov, and Health Canada has authorized 8 drug trials for it since 2013.
- Recruiting worldwide: 165
- Trials authorized in Canada: 8
- FDA orphan approvals: 0
- EU medicines: 0
Newest posted first, of 165 recruiting on ClinicalTrials.gov ↗
- AIM2-NLRP3 Inflammasome Dual Inhibitor on hsCRPNCT07933757 · Not applicable · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · starts Nov 11, 2026
- Early Detection and Kinetics of Sepsis-Induced Coagulopathy in Severe Burn PatientsNCT07914205 · Not reported · Center for Traumatology and Major Burns, Ben Arous · starts Aug 1, 2026
- Effect of Anifrolumab on Arterial Inflammation in Systemic Lupus Erythematosus StudyNCT07913919 · Not applicable · University of Cambridge · starts Nov 28, 2025
- Vascular Inflammation in Atherosclerosis - Whole Body Molecular PET/CT Imaging Using Folate Receptor βNCT07877324 · Not applicable · Turku University Hospital · starts Oct 1, 2026
- Effects of Hourly Stair-Climbing Exercise Snacks on Metabolic and Vascular Health in Adults With PrediabetesNCT07847684 · Not applicable · St. Louis University · starts Oct 1, 2026
- Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 DiabetesNCT07837934 · Phase 2 · Tan Tock Seng Hospital · starts Jul 24, 2025
- Systemic Biochemical Signature and Functional Quality Index of Calcaneal Bone Marrow Aspirate in Adults Undergoing Foot…NCT07802106 · Not reported · Universidade Sao Francisco · starts Oct 21, 2026
- Anticoagulation Combined With Tocilizumab for Interleukin-6 Receptor Inhibition in Acute Cerebral Venous ThrombosisNCT07801638 · Not applicable · Capital Medical University · starts Mar 1, 2025
- PyroEVs/PLIN3 Mediate Lipid Droplet-Mitochondrial Coupling in Sepsis Endothelial InjuryNCT07727265 · Not reported · Zhongda Hospital · starts Jul 1, 2024
Newest first; search them all in Canada trials
| Nov 25, 2025 | A randomized, double blind, placebo controlled phase 4 clinical trial to evaluate the long-term safety and efficacy of avacopan in participants with…Avacopan (amg 569) | Amgen | Pending |
| Jun 4, 2025 | The restart trial: reducing systemic inflammation for people on antiretroviral therapyFostemsavir | Santé Québec- Centre Hospitalier De L’université De Montréal | Pending |
| Feb 13, 2023 | Canagliflozin targeting vascular inflammation: an ottawa imaging study (cantor sing) - a pilot studyCanagliflozin / 18F-fluorodeoxyglucose (18-FDG) | Ottawa Heart Institute Research Corporation | Ongoing |
| Nov 29, 2022 | Low dose naltrexone to improve physical health in patients with vasculitis (lodonavasc)Naltrexone | Peter Merkel | Ongoing |
| Mar 19, 2020 | Arterial inflammation as a risk factor for cardiovascular disease and its prevention through a polyphenol-rich diet: contribution of quantitative tep/tdm…Chus naf / Cyclodx | Ciusss De L'Estrie - Centre Hospitalier Universitaire De Sherbrooke | Pending |
| Feb 26, 2019 | Colchicine for prevention of vascular inflammation in non-cardioembolic stroke ¿ a randomised clinical trial of low-dose colchicine for secondary prevention…Colchicine | University College Dublin | Pending |
| Nov 13, 2014 | A randomized, double-blind, placebo-controlled, dose assessment phase 2 study to evaluate the safety and efficacy of CCX168 in subjects with anti-neutrophil…CCX168/ Rituximab/ Cyclophosphamide | Amgen | Closed |
| Dec 30, 2013 | A randomized, double-blind placebo-controlled study to evaluate the effects of colchicine on vascular inflammation as assessed with positron emission…Colchicine /[18F]-fluorodeoxyglucose (18-FDG) | Montreal Heart Institute | Ongoing |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA